Bethesda North Marriott Hotel & Conference Center, Bethesda, MD USA
May 4 2011 8:00AM - May 5 2011 5:00PM
The First Truly Comprehensive Conference on Biosimilars Since the Enactment of BPCIA in 2010. On March 23, 2010, the Biologics Price Competition and Innovation Act was enacted into law as part of U.S. healthcare reform, establishing an approval pathway for biosimilar biological productsin the US. This Act and the way it is implemented will have huge impact on the development and availability of biological medicines in the US, both from an intellectual property and market access perspective. Hear the perspectives of FDA, industry, lawyers, academics, clinicians, payers and patients on the introduction of biosimilars to the US, including the critical challenges and the current ideas of these stakeholders. Event Code:
11012
|
|